https://doctransparency.com/doctor/tx/san-antonio/chaithanya-mallikarjun-1114101904
Medicare Enrolled

Dr. Chaithanya Mallikarjun, MD

Hepatology Physician · San Antonio, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
19284 STONE OAK PKWY, San Antonio, TX 78258
2102680124
In practice since 2007 (18 years)
NPI: 1114101904 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Mallikarjun from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mallikarjun? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Mallikarjun

Dr. Chaithanya Mallikarjun is a hepatology physician in San Antonio, TX, with 18 years in practice. Based on federal Medicare data, Dr. Mallikarjun performed 1,068 Medicare services across 592 unique beneficiaries.

Between the years covered by Open Payments, Dr. Mallikarjun received a total of $5,157 from 40 pharmaceutical and/or device companies across 262 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hepatology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Mallikarjun is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice▲ Top 14% volume in TX$ $5,157 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,068
Medicare services
Top 14% in TX for hepatology physician
592
Unique beneficiaries
$65
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~59 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Tissue pathology examination, moderate complexity475$25$61
Office visit, established patient (30-39 min)140$90$181
Colonoscopy with biopsy82$70$563
Removal of polyps or growths of large bowel using an endoscope with mechanical snare72$206$803
Upper GI endoscopy with biopsy63$89$608
Hospital follow-up visit, high complexity60$93$254
Special stained specimen slides to examine tissue including interpretation and report48$54$78
Initial hospital admission, high complexity40$136$480
Tissue staining for diagnosis, additional34$45$78
Tissue staining for diagnosis, initial28$51$78
New patient office visit (45-59 min)26$91$291
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$5,157
Total received (2018-2024)
Avg $737/year across 7 years
Bottom 20% in TX for hepatology physician
40
Companies
262
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,525 (87.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$632 (12.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,950
2023
$516
2022
$516
2021
$319
2020
$774
2019
$437
2018
$646

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$846
QOL Medical, LLC
$516
Janssen Biotech, Inc.
$404
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$387
Celgene Corporation
$280
Shire North American Group Inc
$232
Takeda Pharmaceuticals U.S.A., Inc.
$231
Lilly USA, LLC
$222
PFIZER INC.
$219
AbbVie Inc.
$132
Merck Sharp & Dohme LLC
$129
Ferring Pharmaceuticals Inc.
$114
RedHill Biopharma Inc.
$114
Janssen Pharmaceuticals, Inc
$111
Gilead Sciences, Inc.
$95
Braintree Laboratories, Inc.
$92
Celltrion USA Inc.
$88
Merck Sharp & Dohme Corporation
$87
AbbVie, Inc.
$86
Regeneron Healthcare Solutions, Inc.
$85
GENZYME CORPORATION
$77
Ipsen Biopharmaceuticals, Inc
$68
Cumberland Pharmaceuticals, Inc.
$66
UCB, Inc.
$64
AIMMUNE THERAPEUTICS, INC.
$60
Shionogi Inc
$51
Ardelyx, Inc.
$48
EVOKE PHARMA, INC.
$45
Micro-tech Endoscopy USA, Inc.
$25
Mallinckrodt Hospital Products Inc.
$23
CONMED Corporation
$22
Hologic Sales and Service, LLC
$19
VIVUS LLC
$19
Alfasigma USA, Inc.
$18
Boehringer Ingelheim Pharmaceuticals, Inc.
$16
SHIELD THERAPEUTICS INC
$15
Intercept Pharmaceuticals, Inc.
$13
Allergan Inc.
$13
Synergy Pharmaceuticals Inc
$12
Ethicon US, LLC
$11
Top 3 companies account for 34.2% of total payments
Associated products mentioned in payments ›
ACCRUFER · APRISO · All Products · Bylvay · CLENPIQ · CONMED SPECIMEN RETRIEVAL · CREON · CYLTEZO · Cimzia · CoolSeal Generator · DIFICID · DUPIXENT · Dexilant · ENTYVIO · EOHILIA · Entyvio · GATTEX · GIMOTI · HUMIRA · Humira · IBSRELA · IQIRVO · LINZESS · Mavyret · Movantik · OCALIVA · OMVOH · Omeclamox · PANCREAZE · REBYOTA · RELISTOR · REMICADE · RINVOQ · Retrieval Net · SKYRIZI · STELARA · SUCRAID · SUFLAVE · SUPREP · SUPREP BOWEL PREP · SUTAB · Snare · Sucraid · Symproic · TERLIVAZ · TREMFYA · TRULANCE · Talicia · Trulance · VEGZELMA · VIBERZI · VOWST · XARELTO · XELJANZ · XIFAXAN · ZEPATIER · ZEPOSIA · Zelnorm
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (88%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $483 per 100 Medicare services performed
Looking for a hepatology physician in San Antonio?
Compare hepatology physicians in the San Antonio area by procedure volume, costs, and industry payment transparency.
Browse hepatology physicians nearby

Geographic Context

Hepatology Physicians within 10 mi
3
Per 100K population
0.1
County median income
$70,571
Nearest hospital
SOUTH TEXAS SPINE AND SURGICAL HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Mallikarjun is a clinical cardiology specialist, with above-average Medicare volume (top 14% in TX), and low-engagement industry engagement, with 18 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Mallikarjun experienced with tissue pathology examination, moderate complexity?
Based on Medicare claims data, Dr. Mallikarjun performed 475 tissue pathology examination, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Mallikarjun receive payments from pharmaceutical companies?
Yes. Dr. Mallikarjun received a total of $5,157 from 40 companies across 262 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mallikarjun's costs compare to other hepatology physicians in San Antonio?
Dr. Mallikarjun's average Medicare payment per service is $65. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mallikarjun) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →